• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性扩张型心肌病患者预后的临床预测因素

Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy.

作者信息

Karatolios Konstantinos, Holzendorf Volker, Hatzis George, Tousoulis Dimitrios, Richter Anette, Schieffer Bernhard, Pankuweit Sabine

机构信息

Department of Cardiology, Angiology and Intensive Care, Philipps University Marburg, Marburg, Germany.

Clinical Trial Center Leipzig, Faculty of Medicine, University of Leipzig, Leipzig, Germany.

出版信息

PLoS One. 2017 Dec 21;12(12):e0188491. doi: 10.1371/journal.pone.0188491. eCollection 2017.

DOI:10.1371/journal.pone.0188491
PMID:29267340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5739391/
Abstract

OBJECTIVES

The study objectives were to identify predictors of outcome in patients with inflammatory dilated cardiomyopathy (DCMi).

METHODS

From 2004 to 2008, 55 patients with biopsy-proven DCMi were identified and followed up for 58.2±19.8 months. Predictors of outcome were identified in a multivariable analysis with a Cox proportional hazards analysis. The primary endpoint was a composite of death, heart transplantation and hospitalization for heart failure or ventricular arrhythmias.

RESULTS

For the primary endpoint, a QTc interval >440msec (HR 2.84; 95% CI 1.03-7.87; p = 0.044), a glomerular filtration rate (GFR) <60ml/min/1.73m2 (HR 3.19; 95% CI 1.35-7.51; p = 0.008) and worsening of NYHA classification during follow-up (HR 2.48; 95% CI 1.01-6.10; p = 0.048) were univariate predictors, whereas left ventricular ejection fraction at baseline, NYHA class at entry, atrial fibrillation, treatment with digitalis or viral genome detection were not significantly related to outcome. After multivariable analysis, a GFR <60ml/min/1.73m2 (HR 3.04; 95% CI 1.21-7.66; p = 0.018) remained a predictor of adverse outcome.

CONCLUSIONS

In patients with DCMi, a prolonged QTc interval >440msec, a GFR<60ml/min/1.73m2 and worsening of NYHA classification during follow-up were univariate predictors of adverse prognosis. In contrast, NYHA classification at baseline, left ventricular ejection fraction, atrial fibrillation, treatment with digitalis or viral genome detection were not related to outcome. After multivariable analysis, a GFR <60ml/min/1.73m2 remained independently associated with adverse outcome.

摘要

目的

本研究旨在确定炎症性扩张型心肌病(DCMi)患者预后的预测因素。

方法

2004年至2008年,共纳入55例经活检证实的DCMi患者,随访时间为58.2±19.8个月。通过Cox比例风险分析进行多变量分析,确定预后的预测因素。主要终点为死亡、心脏移植以及因心力衰竭或室性心律失常住院的综合情况。

结果

对于主要终点,单因素预测因素包括QTc间期>440毫秒(HR 2.84;95%CI 1.03 - 7.87;p = 0.044)、肾小球滤过率(GFR)<60ml/min/1.73m²(HR 3.19;95%CI 1.35 - 7.51;p = 0.008)以及随访期间纽约心脏协会(NYHA)分级恶化(HR 2.48;95%CI 1.01 - 6.10;p = 0.048),而基线左心室射血分数、入院时NYHA分级、心房颤动、洋地黄治疗或病毒基因组检测与预后无显著相关性。多变量分析后,GFR<60ml/min/1.73m²(HR 3.04;95%CI 1.21 - 7.66;p = 0.018)仍是不良预后的预测因素。

结论

在DCMi患者中,QTc间期延长>440毫秒、GFR<60ml/min/1.73m²以及随访期间NYHA分级恶化是不良预后的单因素预测因素。相比之下,基线NYHA分级、左心室射血分数、心房颤动、洋地黄治疗或病毒基因组检测与预后无关。多变量分析后,GFR<60ml/min/1.73m²仍与不良预后独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd46/5739391/a61cec2466b2/pone.0188491.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd46/5739391/a61cec2466b2/pone.0188491.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd46/5739391/a61cec2466b2/pone.0188491.g001.jpg

相似文献

1
Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy.炎症性扩张型心肌病患者预后的临床预测因素
PLoS One. 2017 Dec 21;12(12):e0188491. doi: 10.1371/journal.pone.0188491. eCollection 2017.
2
Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者的长期预后及预后预测因素
Int J Cardiol. 2016 Oct 1;220:608-12. doi: 10.1016/j.ijcard.2016.06.167. Epub 2016 Jun 26.
3
Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.心脏再同步治疗患者死亡率的决定因素:再同步治疗前的基线临床、超声心动图和血管闪烁造影评估
Pacing Clin Electrophysiol. 2005 Dec;28(12):1260-70. doi: 10.1111/j.1540-8159.2005.00266.x.
4
Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.不同病因对扩张型心肌病患者临床病程及预后的影响。
Eur J Clin Invest. 2015 Sep;45(9):906-17. doi: 10.1111/eci.12483. Epub 2015 Aug 6.
5
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.过去 30 多年来,托斯卡纳地区特发性扩张型心肌病患者生存率的提高:基于证据的管理的影响。
Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25.
6
Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.导致冠心病或非缺血性扩张型心肌病患者 ICD 干预的致室性心律失常的相关因素。
Kardiol Pol. 2012;70(12):1264-75.
7
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.扩张型心肌病的自然病史:从无症状左心室功能不全到心力衰竭——的里雅斯特心肌病登记处的亚组分析
J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):699-705. doi: 10.2459/JCM.0b013e32832bba35.
8
The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者右心室收缩功能障碍的患病率及其预后意义。
Circulation. 2013 Oct 8;128(15):1623-33. doi: 10.1161/CIRCULATIONAHA.113.002518. Epub 2013 Aug 21.
9
Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy.青少年特发性扩张型心肌病的临床过程和风险特征。
Am J Cardiol. 2010 Mar 1;105(5):716-20. doi: 10.1016/j.amjcard.2009.10.055.
10
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy.白细胞介素-1β水平可预测特发性扩张型心肌病门诊患者的长期死亡率及心脏移植需求。
Oncotarget. 2017 Apr 11;8(15):25131-25140. doi: 10.18632/oncotarget.15349.

引用本文的文献

1
Long-Term Prognosis of Suspected Myocarditis and Cardiomyopathy Associated with Viral Infection of the Myocardial Tissue: A Meta-Analysis of Cohort Studies.心肌组织病毒感染相关性疑似心肌炎和心肌病的长期预后:队列研究的荟萃分析。
Cardiovasc Ther. 2019 Dec 16;2019:9342792. doi: 10.1155/2019/9342792. eCollection 2019.
2
Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy.半乳糖凝集素-3 可预测近期起病扩张型心肌病的左心室逆重构。
Dis Markers. 2018 Jun 19;2018:2958219. doi: 10.1155/2018/2958219. eCollection 2018.

本文引用的文献

1
Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.心房颤动与心血管疾病、肾脏疾病和死亡风险:系统评价和荟萃分析。
BMJ. 2016 Sep 6;354:i4482. doi: 10.1136/bmj.i4482.
2
Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者的长期预后及预后预测因素
Int J Cardiol. 2016 Oct 1;220:608-12. doi: 10.1016/j.ijcard.2016.06.167. Epub 2016 Jun 26.
3
Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
心肌内 miR-133a 水平与炎症性心肌病患者的心肌炎症、左心室功能改善和临床结局相关。
Eur J Heart Fail. 2016 Dec;18(12):1442-1451. doi: 10.1002/ejhf.579. Epub 2016 Jun 13.
4
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.扩张型心肌病、运动减弱非扩张型心肌病修订定义的建议及其对临床实践的影响:ESC 心肌和心包疾病工作组立场声明。
Eur Heart J. 2016 Jun 14;37(23):1850-8. doi: 10.1093/eurheartj/ehv727. Epub 2016 Jan 19.
5
Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy.炎症性心肌病患者活检结果变化与超声心动图、临床及实验室参数的相关性
Heart Vessels. 2016 Mar;31(3):416-26. doi: 10.1007/s00380-014-0618-0. Epub 2014 Dec 25.
6
Detailed pathologic evaluation on endomyocardial biopsy provides long-term prognostic information in patients with acute myocarditis.心肌活检的详细病理评估可为急性心肌炎患者提供长期预后信息。
Cardiovasc Pathol. 2014 May-Jun;23(3):139-44. doi: 10.1016/j.carpath.2014.01.004. Epub 2014 Jan 17.
7
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.心肌炎的病因、诊断、治疗和治疗的现有知识状况:欧洲心脏病学会心肌和心包疾病工作组的立场声明。
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3.
8
Renal function has an effect on cardiovascular mortality in patients with dilated cardiomyopathy.肾功能对扩张型心肌病患者的心血管死亡率有影响。
J Cardiovasc Med (Hagerstown). 2012 Sep;13(9):554-8. doi: 10.2459/JCM.0b013e328356a2fd.
9
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组编著。与欧洲心脏病学会心力衰竭协会(HFA)合作制定。
Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19.
10
Update on myocarditis.心肌炎最新进展。
J Am Coll Cardiol. 2012 Feb 28;59(9):779-92. doi: 10.1016/j.jacc.2011.09.074.